
Sign up to save your podcasts
Or
Washington correspondent John Wilkerson joins to discuss why drugmakers have not lobbied against Robert F. Kennedy Jr.'s nomination to lead the Department of Health and Human Services, despite his repeated criticisms of the pharmaceutical industry. We also bring on our colleague Jason Mast to talk about the major hurdles in the field of gene therapy and how one father is trying to overcome them.
4.5
304304 ratings
Washington correspondent John Wilkerson joins to discuss why drugmakers have not lobbied against Robert F. Kennedy Jr.'s nomination to lead the Department of Health and Human Services, despite his repeated criticisms of the pharmaceutical industry. We also bring on our colleague Jason Mast to talk about the major hurdles in the field of gene therapy and how one father is trying to overcome them.
30,845 Listeners
1,040 Listeners
1,789 Listeners
478 Listeners
122 Listeners
84 Listeners
5,942 Listeners
391 Listeners
59 Listeners
29 Listeners
5,462 Listeners
147 Listeners
18 Listeners
51 Listeners
371 Listeners